NORETHINDRONE ACETATE

Indications

Sequential administration during oestrogen replacement therapy in post menopausal women with an intact uterus.

Dosage

In cyclic treatment with oestradiol, norethindrone acetate should be given during last 12 days of each 3 -week period of oestradiol administration, so that the 4th week of each cycle remains without any treatment. In patients receiving continuous oestradiol therapy, norethindrone acetate should be taken for 10-14 days (preferably first 12 claendar days)of each month.